Extensively drug-resistant IMP-16-producing Pseudomonas monteilii isolated from cerebrospinal fluid.
Autor: | Ballaben AS; Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil., Galetti R; Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil., Andrade LN; Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil., Ferreira JC; Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil., de Oliveira Garcia D; Instituto Adolfo Lutz de Marília, Marília, Brazil., Doi Y; Division of Infectious Diseases, University of Pittsburgh, School of Medicine, Pittsburgh, USA; Center for Innovative Antimicrobial Therapy, University of Pittsburgh, School of Medicine, Pittsburgh, USA., Darini ALC; Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil. Electronic address: aldarini@usp.br. |
---|---|
Jazyk: | angličtina |
Zdroj: | Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Infect Genet Evol] 2021 Jan; Vol. 87, pp. 104658. Date of Electronic Publication: 2020 Nov 30. |
DOI: | 10.1016/j.meegid.2020.104658 |
Abstrakt: | IMP-1-producing Pseudomonas aeruginosa was first reported in Japan and since then, bacteria with this metallo-β-lactamase have been detected worldwide. Pseudomonas monteilii (part of P. putida group) were considered an environmental pathogen with low virulence potential; however, multidrug-resistant and carbapenem-resistant P. monteilii have emerged. The present study reports the draft sequence of an extensively drug-resistant IMP-16-producing P. monteilii 597/14 isolated from cerebrospinal fluid in 2014. The sequencing data revealed bla (Copyright © 2020. Published by Elsevier B.V.) |
Databáze: | MEDLINE |
Externí odkaz: |